1 Department of Anatomy, School of Basic Medical Sciences, Benjamin Carson Snr College of Health and Medical Sciences, Babcock University Ilishan-Remo, Ogun State, Nigeria.
2 Department of Anatomy, Faculty of Basic Medical Sciences, Obafemi Awolowo College of Health and Medical Sciences, Olabisi Onabanjo University, Ago Iwoye, Nigeria.
3 Department of Basic Sciences (Biology Unit), School of Science and Technology, Babcock University, Ilishan Remo, Ogun State, Nigeria.
4 Department of Physiology, School of Basic Medical Sciences, Babcock University, Ilisan-Remo, Ogun State, Nigeria.
World Journal of Advanced Research and Reviews, 2026, 29(03), 215-219
Article DOI: 10.30574/wjarr.2026.29.3.0417
Received on 18 February 2026; revised on 18 February 2026; accepted on 19 February 2026
Epilepsy is a global neurological disorder frequently associated with reproductive and endocrine dysfunctions in both males and females. Antiepileptic drug such as Aframomum melegueta has been reported to possess antioxidant and medicinal properties, but its effects on epilepsy-induced ovarian dysfunction remain unexplored. This study evaluates the effects of Aframomum melegueta on reproductive hormones, oxidative stress markers and ovarian histoarchitectural changes in lithium chloride-pilocarpine-induced epileptic female rats. Twenty-four adult female Wistar rats were randomly assigned into four groups (n = 6): control, epileptic (untreated), A. melegueta-treated epileptic and standard antiepileptic drug-treated epileptic groups. Epilepsy was induced using intraperitoneal injection of lithium chloride and pilocarpine. Treatments were administered orally for 21 days. Body and ovarian weights were recorded, serum samples were analyzed for reproductive hormones and oxidative stress indices, and ovarian tissues were examined histologically following sacrifice under diethyl ether anesthesia. Treatment with A. melegueta resulted in a significant increase (p < 0.05) in relative ovarian weight, superoxide dismutase activity, follicle-stimulating hormone, and luteinizing hormone levels compared with the epileptic control and standard drug groups. Malondialdehyde levels significantly reduced in the A. melegueta-treated group relative to the epileptic control but remained higher than those in the standard drug group. Histological analysis of ovaries from epileptic rats showed follicular degeneration, oocyte loss and necrotic changes, whereas these alterations were markedly attenuated in A. melegueta-treated rats. These findings suggest Aframomum melegueta exhibited protective and restorative effects against epilepsy-induced ovarian damage by improving hormonal balance, enhancing antioxidant defense, and preserving ovarian histoarchitecture.
Epilepsy; Aframomum melegueta; Lithium chloride-pilocarpine; Reproductive hormones; Diazepam; ovary
Preview Article PDF
Onyema Kelechi Roselyn, Fabiyi Oluseyi Sunday, Bella Temiloluwa Patience, Kolawole Oluwaseyi Emmanuel, Adelodun Stephen Taiye, Ogunsanya Sanmi Tunde, Dada Moyosoluwa Mary, Sambo Ayuba Jacob, Odubela Olukayode, Adewumi Aderiike Grace and Adeogun Adetomiwa Ezekiel. Aframomum Melegueta protects against Lithium Chloride-Pilocarpine-Induced Epilepsy via HPG axis, Regulates Oxidative Stress and enhances Ovarian Histoarchitectural Integrity in Female Wistar Rats. World Journal of Advanced Research and Reviews, 2026, 29(3), 215-219. Article DOI: https://doi.org/10.30574/wjarr.2026.29.3.0417